Şunu aradınız:: mercaptopurine (Maltaca - İngilizce)

6- mercaptopurine vm26:
6-mercaptopurine vm26:

xaluprine fih mercaptopurine.
xaluprine contains mercaptopurine.

mercaptopurine (użat biex jikkura l-kanċer)
mercaptopurine (used to treat cancer)

effetti ta’ mercaptopurine fuq prodotti mediċinali oħra
effects of mercaptopurine on other medicinal products

trattament flimkien ma’ azathioprine/6-mercaptopurine
concurrent treatment with azathioprine/6-mercaptopurine

6-mercaptopurine huwa metabolizzat mill-enzima polimorfika tpmt.
6–mercaptopurine is metabolised by the polymorphic tpmt enzyme.

hemm dħul baxx ta’ 6–mercaptopurine fil-fluwidu ċerebrospinali.
there is low entry of 6–mercaptopurine into the cerebrospinal fluid.

6–mercaptopurine huwa epatotossiku fl-annimali u fuq il-bniedem.
6–mercaptopurine is hepatotoxic in animals and man.

ml wieħed tas-sospensjoni fih 20 mg ta’ mercaptopurine bħala monohydrate.
one ml of suspension contains 20 mg of mercaptopurine monohydrate.

evidenza tat-teratoġeniċità ta’ 6–mercaptopurine fil-bniedem hija ekwivoka.
evidence of the teratogenicity of 6–mercaptopurine in humans is equivocal.

għid lit-tabib tiegħek jekk qed tieħu azathioprine jew 6- mercaptopurine u humira.
tell your doctor if you are taking azathioprine or 6- mercaptopurine with humira.

ml wieħed ta’ sospensjoni fih 20 mg ta’ mercaptopurine (bħala monohydrate).
one ml of suspension contains 20 mg mercaptopurine (as monohydrate).

is-soppressjoni tal-mudullun hija riversibbli jekk 6–mercaptopurine jitwaqqaf kmieni biżżejjed.
bone marrow suppression is reversible if 6–mercaptopurine is withdrawn early enough.

6–mercaptopurine juri varjazzjoni diurnali fir-rigward tal-farmakokinetika u l-effikaċja.
6–mercaptopurine displays diurnal variation in pharmacokinetics and efficacy.

għid lit-tabib tiegħek jekk qed tieħu azathioprine jew 6-mercaptopurine flimkien ma’ simponi.
tell your doctor if you are taking azathioprine or 6-mercaptopurine with simponi.

fuljett ta’ tagħrif: informazzjoni għall-utent xaluprine 20 mg/ml sospensjoni orali mercaptopurine
package leaflet: information for the user xaluprine 20 mg/ml oral suspension mercaptopurine

xi wħud minn-dawn il-pazjenti kienu wkoll qed jiġu ttrattati b’ azathioprine jew 6- mercaptopurine.
some of those patients were also treated with azathioprine or 6- mercaptopurine.

Ġiet irrapportata oligospermia profonda temporanja wara l-espożizzjoni għal 6–mercaptopurine f’kombinazzjoni ma’ kortikosterojdi.
transient profound oligospermia has been reported following exposure to 6–mercaptopurine in combination with corticosteroids.

allopurinol u inibituri oħra ta’ xanthine oxidase jnaqqsu r-rata ta’ kataboliżmu ta’ 6–mercaptopurine.
allopurinol and other xanthine oxidase inhibitors decrease the rate of catabolism of

Ġiet irrapportata inibizzjoni tal-effett anti-koagulanti ta’ warfarin, meta jingħata ma’ 6-mercaptopurine.
inhibition of the anticoagulant effect of warfarin, when given with 6–mercaptopurine, has been reported.